This book covers both sides of the debate over amphetamine prescription and use. It discusses the history of amphetamine and related stimulants; ADHD and the use of Ritalin and Adderall to treat it; related neuroenhancers; methamphetamine from Desoxyn to crystal meth; the nature of addiction and side effects; sociological effects of amphetamine compounds; and expert opinions for and against amphetamine use.

Medicine.

Khat. A harmless natural stimulant or a lethal epidemic sweeping through the international drugs trade? Khat is a natural substance that, in the Middle East, is as ubiquitous as coffee is in the West. It is hugely popular in some African and Arab populations. But critics contend that it is a seriously addictive stimulant that damages the cardiovascular system. In a groundbreaking study, the authors go behind the veil of the drug, questioning its availability and its effect on its Red Sea producers. Interwoven with case studies from Djibouti to Rome, The Khat Controversy goes deeper to explore contemporary issues relating to globalization, ethnicity and culture. With its popularity escalating in London, Rome, Toronto and Copenhagen, khat is fast becoming a problem in the West. The first study of this contested drug, The Khat Controversy provides a concise introduction to the issues surrounding khat usage and suggests how policymakers should address them. The Khat Controversy: Stimulating the Debate on Drugs has received an honorable mention for the African Studies Association's 2008 Melville J. Herskovits Award

Stimulant drugs are widely used in the treatment of ADHD in children and adults. Hundreds of studies over the past 60 years have demonstrated their effectiveness in improving attention span, increasing impulse control, and reducing hyperactivity and restlessness. Despite widespread interest in these compounds, however, their mechanisms of action in the central nervous system have remained poorly understood. Recent advances in the basic and clinical neurosciences now afford the possibility of elucidating these mechanisms. The current volume is the first to bring this expanding knowledge to bear on the central question of why and how stimulants exert their therapeutic effects. The result is a careful, comprehensive, and insightful integration of material by well-known scientists that significantly advances our understanding of stimulant effects and charts a course for future research. Part I presents a comprehensive description of the clinical features of ADHD and the clinical response to stimulants. Part II details the cortical and subcortical neuroanatomy and functional neurophysiology of dopamine and norepinephrine systems with respect to the regulation of attention, arousal, activity, and impulse control and the effects of stimulants on these systems. Part III is devoted to clinical research, including recent studies of neuroimaging, genetics, pharmacodynamic and pharmacokinetic properties of stimulants, effects on cognitive functions, neurophysiological effects in humans with and without ADHD and in non-human primates, and comparison of stimulants and non-stimulants in the treatment of ADHD. Part IV is a masterful synthesis that presents alternative models of stimulant drug action and generates key hypotheses for continued research. The volume will be of keen interest to researchers and clinicians in psychiatry, psychology, and neurology, neuroscientists studying stimulants, and those pursuing development of new drugs to treat ADHD.

In a book as provocative and newsworthy as Listening to Prozac and Driven to Distraction, a physician speaks out on America's epidemic level of diagnoses for attention deficit disorder, and on the drug that has become almost a symbol of our times: Ritalin. In 1997 alone, nearly five million people in the United States were prescribed Ritalin--most of them young children diagnosed with attention deficit disorder. Use of this drug, which is a stimulant related to amphetamine, has increased by 700 percent since 1990. And this phenomenon appears to be uniquely American: 90 percent of the world's Ritalin is used here. Is this a cause for alarm--or simply the case of an effective treatment meeting a newly discovered need? Important medical advance--or drug of abuse, as some critics claim? Lawrence Diller has written the definitive book about this crucial debate--evenhanded, wide-ranging, and intimate in its knowledge of families, schools, and the pressures of our speeded-up society. As a pediatrician and family therapist, he has evaluated hundreds of children, adolescents, and adults for ADD, and he offers crucial information and treatment options for anyone struggling with this problem. Running on Ritalin also throws a spotlight on some of our most fundamental values and goals. What does Ritalin say about the old conundrums of nature vs. nurture, free will vs. responsibility? Is ADD a disability that entitles us to special treatment? If our best is not good enough, can we find motivation and success in a pill? Is there still a place for childhood in the performance-driven America of the late nineties?

This volume addresses the interface of two major national problems: the epidemic of HIV-AIDS and the widespread use of illegal injection drugs. Should communities have the option of giving drug users sterile needles or bleach for cleaning needs in order to reduce the spread of HIV? Does needle distribution worsen the drug problem, as opponents of such programs argue? Do they reduce the spread of other serious diseases, such as hepatitis? Do they result in more used needles being carelessly discarded in the community? The panel takes a critical look at the available data on needle exchange and bleach distribution programs, reaches conclusions about their efficacy, and offers concrete recommendations for public policy to reduce the spread of HIV/AIDS. The book includes current knowledge about the epidemiologies of HIV/AIDS and injection drug use; characteristics of needle exchange and bleach distribution programs and views on those programs from diverse community groups; and a discussion of laws designed to control possession of needles, their impact on needle sharing among injection drug users, and their implications for needle exchange programs.

The proposed book will discuss various aspects of big data Analytics. It will deliberate upon the tools, technology, applications, use cases and research directions in the field. Chapters would be contributed by researchers, scientist and practitioners from various reputed universities and organizations for the benefit of readers.

This completely revised and updated secong edition of the Drug Legalization Debate continues to address, and offer alternatives to, the major issues.

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters. Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals. - Includes chapters written by international experts in the field - Presents a comprehensive overview on the classification, detection, availability and supply of novel psychoactive substances, in addition to the pharmacology and toxicology associated with the substance - Offers a single source for all interested parties working in this area, including scientists, academics, clinicians, law enforcement and regulatory agencies - Provides a full treatment of novel psychoactive substances that have recently emerged onto the recreational drug scene, including amphetamines and the synthetic cannabinoid receptors in 'spice' and 'K2'

Containing more than 450 entries, this easy-to-read encyclopedia provides concise information about the history of and recent trends in drug use and drug abuse in the United States—a societal problem with an estimated cost of $559 billion a year. Despite decades of effort and billions of dollars spent to combat the problem, illicit drug use in the United States is still rampant and shows no sign of abating. Covering illegal drugs ranging from marijuana and LSD to cocaine and crystal meth, this authoritative reference work examines patterns of drug use in American history, as well as drug control and interdiction efforts from the nineteenth century to the present. This encyclopedia provides a multidisciplinary perspective on the various aspects of the American drug problem, including the drugs themselves, the actions taken in attempts to curb or stop the drug trade, the efforts at intervention and treatment of those individuals affected by drug use, and the cultural and economic effects of drug use in the United States. More than 450 entries descriptively analyze and summarize key terms, trends, concepts, and people that are vital to the study of drugs and drug abuse, providing readers of all ages and backgrounds with invaluable information on domestic and international drug trafficking and use. The set provides special coverage of shifting societal and legislative perspectives on marijuana, as evidenced by Colorado and Washington legalizing marijuana with the 2012 elections.